Current and Future Directions in Fluorescence Imaging-Guided Debridement
Advances in Wound Care · 01.08.2025 · 14 (8) · 409-417
DOI: 10.1089/wound.2024.0067 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Wound Care, erschienen am 01.08.2025. Verfasst von Rachael Orkin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Debridement, Optical Imaging, Diabetic Foot, Wound Infection. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Significance: Sterility and reduction of the bioburden are crucial for healing in chronic wounds such as diabetic foot ulcers. Although there are methods for measuring bioburdens, such as semiquantitative analysis of swab/biopsy samples, microbiological sampling, and molecular diagnostics, these tools are less accessible owing to costs or not being as quick as other methods. These methods are also dependent on clinical assessment by the clinician, and high bacterial burden may appear asymptomatic. Recent Advances: Autofluorescence (AF) imaging is a novel technology for identifying and quantifying chronic inhibitory bacterial load in chronic wounds. Eighty-seven percent of bacteria that frequent chronic wounds have fluorophores that fluoresce under violet light as red or cyan, depending on the type of fluorophore. Therefore, AF image-guided treatment is becoming increasingly effective for physicians to implement wound dressing changes and debridement because bacterial burdens are difficult to locate clinically. Critical Issue: Products such as the commercially available MolecuLight i:X and MolecuLight DX function as handheld cameras for physicians to use as a reference but require additional work to ensure that the photograph will be taken with adequate lighting. Future Directions: Designs for Vision Inc. introduced a device called REVEAL, an AF imaging form factor that allows the device to be worn on top of a pair of glasses, which the physician would wear intraoperatively. The benefits of this form factor include not requiring certain lighting conditions and not having to interpret the results using a handheld camera, allowing the device to be used during active surgical debridement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Terasaki Institute for Biomedical Innovations, Los Angeles, California, USA.
ORCID-Profile: Johnson V John
Förderung
- NIDDK NIH HHS
Zitieren
APA
Orkin, R., Sharma, A., John, J. V., & Armstrong, D. G. (2025). Current and Future Directions in Fluorescence Imaging-Guided Debridement. Advances in Wound Care, 14(8), 409-417. https://doi.org/10.1089/wound.2024.0067
Vancouver
Orkin R, Sharma A, John JV, Armstrong DG. Current and Future Directions in Fluorescence Imaging-Guided Debridement. Advances in Wound Care. 2025;14(8):409-417. doi:10.1089/wound.2024.0067
BibTeX
@article{Orkin2025,
author = {Orkin, Rachael and Sharma, Arjun and John, Johnson V and Armstrong, David G},
title = {Current and Future Directions in Fluorescence Imaging-Guided Debridement},
journal = {Advances in Wound Care},
year = {2025},
volume = {14},
number = {8},
pages = {409--417},
doi = {10.1089/wound.2024.0067}
}
EUVIMED